# AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission

> clinical trial · VERIFIED · 2026-07-16

Status: ACTIVE_NOT_RECRUITING · Sponsor: M.D. Anderson Cancer Center · Condition: Acute Myeloid Leukemia in Remission

- Company: M.D. Anderson Cancer Center
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04062266

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.